(29 days)
No
The description focuses on the physical characteristics and intended use of a guide wire, with no mention of AI or ML capabilities.
No.
Explanation: The device is a guide wire intended to facilitate the delivery of other interventional devices during procedures like PTCA and PTA, and to provide a pathway within vessels. It is not directly used to treat or cure a disease or condition. While used during therapeutic procedures, it is a tool for device delivery, not a therapeutic agent itself.
No
This device is a guide wire used to facilitate the delivery of other interventional devices and distinguish vasculature, but it does not independently diagnose conditions. While it can "distinguish the vasculature," this is for guiding other devices, not for diagnosing a condition itself.
No
The device description clearly describes a physical guide wire with specific material properties, dimensions, and coatings, which is a hardware medical device, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a device used during a medical procedure (PTCA and PTA) to facilitate the delivery of other devices and navigate within the body. This is an interventional device, not a diagnostic one.
- Device Description: The description details the physical characteristics of a guide wire, which is a tool used in procedures, not for analyzing samples outside the body.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, tissue, etc.), detecting markers, or providing diagnostic information based on in vitro analysis.
IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This guide wire does not fit that description.
N/A
Intended Use / Indications for Use
Intended to facilitate the delivery of catheter-based interventional devices during percutaneous transluminal coronary angioplasty (PTCA) and percutaneous transluminal angioplasty (PTA). This guide wire may be used with compatible stent devices during therapeutic procedures. The guide wire may be used to reach and cross a target lession, provide a pathway within the vessel structure, facilitate the substitution of one diagnostic or interventional device for another, and to distinguish the vasculature. This guide wire may also be used to crossing de novo chronic total coronary occlusions (CTO).
Product codes
DQX
Device Description
The HI-TORQUE (HT) InfilTrac Guide Wire Family includes steerable guide wires offered in several tip load and guide wire length configurations.
The HT InfilTrac Guide Wire Family will be available with the features as listed below:
- 2 tip loads: 11g and 14g
- . 1 coating length: Uncoated Tip
- 1 tip shape: Pre-shaped, micro-J
- 2 lengths: 190 cm, 300cm
The HT InfilTrac Guide Wires are designed to be compatible with devices designed for use with 0.014" guide wires. The HT InfilTrac Guide Wire Family has a maximum diameter of 0.0144". The distal tip has a radiopaque length of 3.0 cm.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The HT InfilTrac Guide Wire Family was subjected to performance testing which included in-vitro bench and simulated use testing. Results of these tests demonstrated that the HT InfilTrac Guide Wire Family met the functional, dimensional and simulated use testing acceptance criteria requirements as specified in the product specification and external guidance documents. All the outputs tested for HT InfilTrac Guide Wire Family met specification or requirements. Based on the results, Abbott Vascular considers that the HT InfilTrac Guide Wire Family is substantially equivalent to the predicate device- HT Progress Guide Wire.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1330 Catheter guide wire.
(a)
Identification. A catheter guide wire is a coiled wire that is designed to fit inside a percutaneous catheter for the purpose of directing the catheter through a blood vessel.(b)
Classification. Class II (special controls). The device, when it is a torque device that is manually operated, non-patient contacting, and intended to manipulate non-cerebral vascular guide wires, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, with the letters "FDA" in a blue square. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
December 11, 2019
Abbott Vascular Aniket Khakhadiya Senior Specialist, Regulatory Affairs 3200 Lakeside Drive Santa Clara, California 95054
Re: K193126
Trade/Device Name: HI-TORQUE InfilTrac Guide Wire Family Regulation Number: 21 CFR 870.1330 Regulation Name: Catheter Guide Wire Regulatory Class: Class II Product Code: DQX Dated: November 8, 2019 Received: November 12, 2019
Dear Aniket Khakhadiya:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
1
801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4. Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/ training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatory-assistance/contact-usdivision-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Lydia Glaw, Ph.D. Assistant Director DHT2C: Division of Coronary and Peripheral Interventional Devices OHT2: Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K193126
Device Name HI-TORQUE InfilTrac Guide Wire Family
Indications for Use (Describe)
Intended to facilitate the delivery of catheter-based interventional devices during percutaneous transluminal coronary angioplasty (PTCA) and percutaneous transluminal angioplasty (PTA). This guide wire may be used with compatible stent devices during therapeutic procedures. The guide wire may be used to reach and cross a target lession, provide a pathway within the vessel structure, facilitate the substitution of one diagnostic or interventional device for another, and to distinguish the vasculature. This guide wire may also be used to crossing de novo chronic total coronary occlusions (CTO).
| Type of Use (Select one or both, as applicable) |
|---|
| ☑Prescription Use (Part 21 CFR 801 Subpart D) |
| ☐Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
SECTION 2 510(K) SUMMARY
The 510(k) Summary is submitted in accordance with 21 CFR §807.92 and the requirements of the Safe Medical Device Act (SMDA) of 1990.
| 1. | Submitter's Name | Abbott Vascular
(with Business Trade Name as Abbott Medical) |
|----|-------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------|
| | 2. Submitter's Address | 3200 Lakeside Dr., Santa Clara, CA 95054 |
| | 3. Telephone | 408-845-8314 |
| | 4. Fax | 408-845-3743 |
| | 5. Contact Person | Aniket Khakhadiya |
| | 6. Date Prepared | December 10, 2019 |
| | 7. Device Trade Name | HI-TORQUE InfilTrac™ Guide Wire Family |
| | 8. Device Common Name | Guide Wire |
| | 9. Device Classification Name | Catheter Guide Wire (21 CFR 870.1330; Product Code DQX) |
| | 10. Predicate Device Name | HT Progress Guide Wire (K123067, cleared on January
29, 2013) |
| | 11. Reference Devices | HT TurnTrac Guide Wire Family (K173795, cleared on
January 12, 2018)
HT Cross-IT XT Guide Wire (K990639, cleared on
March 25, 1999) |
12. Device Description
The HI-TORQUE (HT) InfilTrac Guide Wire Family includes steerable guide wires offered in several tip load and guide wire length configurations.
The HT InfilTrac Guide Wire Family will be available with the features as listed below:
- 2 tip loads: 11g and 14g
- . 1 coating length: Uncoated Tip
- 1 tip shape: Pre-shaped, micro-J
- 2 lengths: 190 cm, 300cm
The HT InfilTrac Guide Wires are designed to be compatible with devices designed for use with 0.014" guide wires. The HT InfilTrac Guide Wire Family has a maximum diameter of 0.0144". The distal tip has a radiopaque length of 3.0 cm.
4
13. Indication for Use
Intended to facilitate the delivery of catheter-based interventional devices during percutaneous transluminal coronary angioplasty (PTCA) and percutaneous transluminal angioplasty (PTA). This guide wire may be used with compatible stent devices during therapeutic procedures. The guide wire may be used to reach and cross a target lesion, provide a pathway within the vessel structure, facilitate the substitution of one diagnostic or interventional device for another, and to distinguish the vasculature. This guide wire may also be used to cross or assist in crossing de novo chronic total coronary occlusions (CTO).
14. Technological Characteristics and Substantial Equivalence
The HT InfilTrac Guide Wire Family has the same Indications for Use and is also technologically equivalent to the predicate device - HT Progress Guide Wire. They use similar functional specifications, operating principle, materials and design (with minor modifications). They have the same sterilization method, shelf life and packaging components-materials.
A comparison between the subject device - HT InfilTrac Guide Wire Family and its predicate was performed to support a substantial equivalence determination. The substantial equivalence comparison included the device's indications for use, design, technological characteristics, materials, operating principle, sterilization, shelf life and packaging. The conclusion of the comparison analysis is that the subject device - HT InfilTrac Guide Wire Family is substantially equivalent to the currently marketed predicate device - HT Progress Guide Wire.
15. Performance Data
The HT InfilTrac Guide Wire Family was subjected to performance testing which included in-vitro bench and simulated use testing. Results of these tests demonstrated that the HT InfilTrac Guide Wire Family met the functional, dimensional and simulated use testing acceptance criteria requirements as specified in the product specification and external guidance documents. All the outputs tested for HT InfilTrac Guide Wire Family met specification or requirements. Based on the results, Abbott Vascular considers that the HT InfilTrac Guide Wire Family is substantially equivalent to the predicate device- HT Progress Guide Wire.
16. Conclusions
Test results from the performance testing conducted demonstrates that the HT InfilTrac Guide Wire Family met all acceptance criteria requirements. Therefore, Abbott Vascular considers the subject device - HI-TORQUE InfilTrac Guide Wire Family to be substantially equivalent to the currently marketed predicate device - HT Progress Guide Wire.